One study has shown that administering afatinib and paclitaxel to NSCLC cells resistant to EGFR TKIs using a pulmonary microsphere system led to effective treatment of drug-resistant lung cancer [178]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.